Innovations in diagnostics and treatments are advancing rapidly. King's College London researchers developed a nanoneedle patch offering painless tissue molecular sampling, potentially replacing biopsies in cancer and neurodegenerative diseases. Meanwhile, Simtra BioPharma Solutions partnered with MilliporeSigma to streamline antibody-drug conjugate manufacturing amid a growing ADC market. BioMérieux expanded its infectious disease diagnostics portfolio by acquiring Day Zero Diagnostics, incorporating next-generation sequencing and AI to accelerate pathogen detection and antibiotic resistance profiling.